硕世生物
(688399)
| 流通市值：39.71亿 | | | 总市值：39.71亿 |
| 流通股本：5667.01万 | | | 总股本：5667.01万 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 329,915,492.31 | 810,632,720.07 | 1,203,437,423.04 | 1,620,001,671.49 |
| 应收票据及应收账款 | 55,678,822.98 | 53,894,941.97 | 62,232,833.69 | 72,187,067.29 |
| 其中：应收票据 | 500,000 | 72,900 | 2,324,734 | 825,796 |
| 应收账款 | 55,178,822.98 | 53,822,041.97 | 59,908,099.69 | 71,361,271.29 |
| 应收款项融资 | 1,257,612.11 | - | - | - |
| 预付款项 | 24,302,808.3 | 17,981,566.48 | 22,654,202.92 | 24,054,137.48 |
| 其他应收款合计 | 5,823,665.06 | 5,189,406.53 | 5,989,838.72 | 6,082,990.79 |
| 存货 | 59,168,414.06 | 67,044,790.5 | 100,168,273.87 | 98,998,370.43 |
| 其他流动资产 | 28,843,520.49 | 46,699,908.78 | 30,270,062.94 | 15,954,511.33 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 2,133,253,327.45 | 2,139,295,851.19 | 2,295,669,155.72 | 2,710,475,529.63 |
| 非流动资产: | | | | |
| 长期股权投资 | 218,149,683.1 | 220,009,246.49 | 111,407,181.63 | 110,605,582.88 |
| 其他权益工具投资 | 4,138,483.28 | 4,138,483.28 | - | - |
| 其他非流动金融资产 | 234,808,800.22 | 225,846,644.93 | 332,476,884.97 | 290,859,708.73 |
| 固定资产 | 551,278,093.21 | 558,418,470.33 | 573,905,153.88 | 580,160,639.84 |
| 在建工程 | 5,011,980.36 | 4,935,051.94 | 2,800,498 | 2,111,518 |
| 使用权资产 | 12,401,114.04 | 13,881,136.59 | 15,488,609.35 | 9,910,329.17 |
| 无形资产 | 26,856,450.09 | 27,448,295.07 | 28,046,343.87 | 26,341,187.74 |
| 长期待摊费用 | 30,349,725.59 | 34,576,792.64 | 38,807,490.49 | 45,337,416.15 |
| 递延所得税资产 | 73,870,601.38 | 75,013,718.59 | 75,197,311.79 | 77,154,544 |
| 其他非流动资产 | 579,206,920.99 | 436,384,325.62 | 383,068,148.75 | 151,256,916.66 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 1,736,071,852.26 | 1,600,652,165.48 | 1,561,197,622.73 | 1,293,737,843.17 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 3,869,325,179.71 | 3,739,948,016.67 | 3,856,866,778.45 | 4,004,213,372.8 |
| 流动负债: | | | | |
| 短期借款 | 366,150,685.59 | 227,689,730.37 | 312,109,902.21 | 309,108,110.43 |
| 应付票据及应付账款 | 23,186,368.66 | 23,853,281.19 | 19,773,439.23 | 19,277,079.17 |
| 应付账款 | 23,186,368.66 | 23,853,281.19 | 19,773,439.23 | 19,277,079.17 |
| 合同负债 | 25,100,145.14 | 38,757,303.5 | 34,676,729.83 | 33,738,874.96 |
| 应付职工薪酬 | 18,174,608.51 | 16,141,706.14 | 19,351,335.39 | 21,505,308.67 |
| 应交税费 | 2,329,442.18 | 1,976,128.14 | 1,683,808.67 | 1,755,915.44 |
| 其他应付款合计 | 44,932,125.19 | 52,592,305.53 | 48,615,626.27 | 52,672,420.13 |
| 一年内到期的非流动负债 | 2,037,269 | 5,637,655.76 | 5,405,101.23 | 5,286,295.37 |
| 其他流动负债 | 3,084,775.96 | 1,170,347.22 | 1,014,644.11 | 986,630.81 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 484,995,420.23 | 367,818,457.85 | 442,630,586.94 | 444,330,634.98 |
| 非流动负债: | | | | |
| 租赁负债 | 9,713,273.42 | 7,221,290.78 | 8,914,780.82 | 3,851,063.8 |
| 长期应付职工薪酬 | 50,000,000 | 50,000,000 | 50,000,000 | 50,000,000 |
| 递延收益 | 61,165,026.79 | 64,276,240.67 | 68,322,478.32 | 71,687,249.01 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 120,878,300.21 | 121,497,531.45 | 127,237,259.14 | 125,538,312.81 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 605,873,720.44 | 489,315,989.3 | 569,867,846.08 | 569,868,947.79 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 56,670,082 | 56,670,082 | 58,620,000 | 58,620,000 |
| 资本公积 | 661,060,070.73 | 661,060,070.73 | 808,398,727.5 | 806,598,045.45 |
| 减:库存股 | - | - | 147,020,312.08 | - |
| 其他综合收益 | -4,982,289.21 | -4,982,289.21 | - | - |
| 盈余公积 | 29,310,000 | 29,310,000 | 29,310,000 | 29,310,000 |
| 未分配利润 | 2,521,393,595.75 | 2,508,574,163.85 | 2,537,690,516.95 | 2,539,816,379.56 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 3,263,451,459.27 | 3,250,632,027.37 | 3,286,998,932.37 | 3,434,344,425.01 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 3,263,451,459.27 | 3,250,632,027.37 | 3,286,998,932.37 | 3,434,344,425.01 |
| 负债和股东权益合计 | 3,869,325,179.71 | 3,739,948,016.67 | 3,856,866,778.45 | 4,004,213,372.8 |
| 公告日期 | 2025-04-30 | 2025-04-19 | 2024-10-26 | 2024-08-31 |
| 审计意见(境内) | | 标准无保留意见 | | |